XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
2017 PIPE Warrant Liability [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Essentialis, Inc. [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
2017 PIPE Warrant Liability [Member]
Additional Paid-In Capital [Member]
Essentialis, Inc. [Member]
Accumulated Deficit [Member]
Balances at beginning at Dec. 31, 2017 $ 26,817     $ 19   $ 140,495     $ (113,697)
Balances at beginning (shares) at Dec. 31, 2017     4,571 19,238,972          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation 200         200      
Issuance of common stock on conversion of series B convertible preferred shares 1     $ 1          
Issuance of common stock on conversion of series B convertible preferred shares (shares)     (1,000) 200,000          
Issuance of restricted common stock for bonuses 159         159      
Issuance of restricted common stock for bonuses (shares)       99,217          
Issuance of common stock to board members in lieu of cash payments for quarterly board fees 82         82      
Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares)       49,519          
Transaction costs for common stock and warrant issuance.   $ (203)         $ (203)    
Issuance of common stock held back on acquisition of Essentialis (Shares)         180,667        
Net loss (3,804)               (3,804)
Balances at ending at Mar. 31, 2018 23,252     $ 20   140,733     (117,501)
Balances at end (shares) at Mar. 31, 2018     3,571 19,768,375          
Balances at beginning at Dec. 31, 2017 26,817     $ 19   140,495     (113,697)
Balances at beginning (shares) at Dec. 31, 2017     4,571 19,238,972          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (10,862)                
Balances at ending at Jun. 30, 2018 16,649     $ 21   141,187     (124,559)
Balances at end (shares) at Jun. 30, 2018       21,413,867          
Balances at beginning at Mar. 31, 2018 23,252     $ 20   140,733     (117,501)
Balances at beginning (shares) at Mar. 31, 2018     3,571 19,768,375          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation 199         199      
Issuance of common stock on conversion of series B convertible preferred shares (1)         (1)      
Issuance of common stock on conversion of series B convertible preferred shares (shares)     (3,571) 714,200          
Issuance of common stock to board members in lieu of cash payments for quarterly board fees 54         54      
Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares)       27,925          
Transaction costs for common stock and warrant issuance.   $ 203         $ 203    
Issuance of common stock held back on acquisition of Essentialis         $ 1     $ (1)  
Issuance of common stock held back on acquisition of Essentialis (Shares)         903,367        
Net loss (7,058)               (7,058)
Balances at ending at Jun. 30, 2018 16,649     $ 21   141,187     (124,559)
Balances at end (shares) at Jun. 30, 2018       21,413,867          
Balances at beginning at Dec. 31, 2018 30,413     $ 32   157,413     (127,032)
Balances at beginning (shares) at Dec. 31, 2018       31,755,169          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation 202         202      
Issuance of common stock to board members in lieu of cash payments for quarterly board fees 46         46      
Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares)       21,415          
Net loss (7,030)               (7,030)
Balances at ending at Mar. 31, 2019 23,631     $ 32   157,661     (134,062)
Balances at end (shares) at Mar. 31, 2019       31,776,584          
Balances at beginning at Dec. 31, 2018 30,413     $ 32   157,413     (127,032)
Balances at beginning (shares) at Dec. 31, 2018       31,755,169          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (17,038)                
Balances at ending at Jun. 30, 2019 13,843     $ 32   157,881     (144,070)
Balances at end (shares) at Jun. 30, 2019       31,793,292          
Balances at beginning at Mar. 31, 2019 23,631     $ 32   157,661     (134,062)
Balances at beginning (shares) at Mar. 31, 2019       31,776,584          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation 175         175      
Issuance of common stock to board members in lieu of cash payments for quarterly board fees 45         45      
Issuance of common stock to board members in lieu of cash payments for quarterly board fees (shares)       16,708          
Net loss (10,008)               (10,008)
Balances at ending at Jun. 30, 2019 $ 13,843     $ 32   $ 157,881     $ (144,070)
Balances at end (shares) at Jun. 30, 2019       31,793,292